© 2018 Aston Sci. Inc. All rights reserved.
Aston Sci.'s press release archive.
Besides the HPV vaccine, therapies to prevent hepatitis B, which can cause liver cancer, were created as well. These vaccines were the first-ever anti-cancer preventative treatments.
While these vaccines have been widely used to prevent the spread of infection, cancer vaccines have evolved as a treatment method for the disease. In 1990, Bacillus Calmette-Guérin – a vaccine for tuberculosis (TB) – became the first immunotherapy to be approved by the FDA, for the treatment of early-stage bladder cancer. Since then, the potential for oncological vaccine immunotherapies to boost the immune system’s ability to target antigens has been studied and successfully administered in patients, despite some challenges with regard to immunogenicity – the ability of an antigen to provoke an immune response.
As various biotechs across the world specialize in the production of cancer vaccines for different indications, here are 10 companies, presented in alphabetical order, making progress in the field of vaccine development for cancer.
Source: LABIOTECH